Niemann-Pick disease type C (NPC) is a fatal autosomal recessive lipid storage disease associated with impaired trafficking of unesterified cholesterol and glycolipids in lysosomes and late endosomes. This disease is commonly characterized by hepatosplenomegaly and severe progressive neurological dysfunction. There are two defective genes that cause this illness. One of these genes is NPC1 gene which is the cause of illness in 95% of the patients. The other gene is the rare type NPC2 which is the cause of illness in 5% of the patients. Patients with NPC2 usually present with respiratory distress in early infancy, which is rather unusual with NPC1. This article discusses about a patient who died at an early age from pulmonary involvement and who subsequently was found to have a novel homozygous mutation of NPC2 gene.
Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269–81.
Minai OA, Sullivan EJ, Stoller JK. Pulmonary involvement in Niemann–Pick disease: case report and literature review. Respir Med 2000;94:1241–51.
Schofer O, Mischo B, Puschel W, Harzer K, Vanier MT. Early lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group. Eur J Pediatr 1998;157:45–9.
Verot L, Chikh K, Freydiere E, Honore R, Vanier MT, et al. Niemann-Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2. Clin Genet 2007;71:320–30.
Neufeld EB, Wastney M, Patel S, Suresh S, Cooney AM, et al. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 1999;274:9627–35.
Blanchette-Mackie EJ. Intracellular cholesterol trafficking: role of the NPC1 protein. Biochim Biophys Acta 2000;1486:171–83.
Patterson MC, Vanier MT, Suzuki K, Morris JA, Carstea ED, et al. Niemann-Pick disease type C: a lipid trafficking disorder. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, et al., editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3611–34.
Vanier MT, Suzuki K. Niemann-Pick diseases. In: Vinken PJ, Bruyn GW editors. Handbook of clinical neurology. Neurodystrophies and neurolipidoses. Amsterdam: Elsevier Science, 1996:133–62.
Griese M, Brasch F, Aldana VR, Cabrera MM, Goelnitz U, et al. Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis. Clin Genet 2010;77:119–30.
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215–35.
Bjurulf B, Spetalen S, Erichsen A, Vanier MT, Strøm EH, et al. Niemann-Pick disease type C2 presenting as fatal pulmonary alveolar lipoproteinosis: morphological findings in lung and nervous tissue. Med Sci Monit 2008;14:71–5.
Alavi A, Nafissi S, Shamshiri H, Nejad MM, Elahi E. Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C. Mol Genet Metab 2013;110:139–44.
©2015 by De Gruyter.
